Emerald Health Therapeutics has signed an agreement with Skye Bioscience.
Oxford Cannabinoid Technologies has applied to be admitted to the OTC QB Market in the United States.
The British producer of medicinal cannabis oils has announced the appointment of Peter Donovan as global commercial director.
Swiss Life Sciences says it aims to improve on cannabis medicines that are already being successfully used in treatments with elite genetics.
BioHarvest Sciences says the groundbreaking structure is instrumental in the ability to grow trichome cells in bioreactors at scale.
This is the first acquisition made since Yooma completed its dual-listing on the AQSE Growth Market in London.
The hemp products will not contain any THC or CBD.
The exclusive agreement will enable the distribution of Panaxia's advanced medical cannabis products in Poland.
Flowr will be growing some of the most recognisable cannabis strains in the world, including Gelatti and Pink Runtz, in Portugal.
Tilray says the move will facilitate a path to the US cannabis market.
Extracts are currently the fastest growing product in the German medical cannabis market.
The study looked at the effects of broad-spectrum white light on plant yield, morphology, development and quality in cannabis.
The products will benefit European patients with rapid on-set effects within five to 15 minutes alongside improved absorption efficiency.